Defining relative mutational difficulty to understand cancer formation and prevention
H. Jiang, L. Shan, J. Yu, J. Z. He, S. S. Chen, X. M. Liu, Y. H. Ding, L. Xu, J. Zhao, L. A. Yang
Abstract
Most mutations in human cancer are low-frequency missense mutations, whose functional status remains hard to predict. Here we show that depending on the type of nucleotide change and the surrounding sequences, the tendency to generate each type of nucleotide mutations varies greatly, even by several hundred folds. Therefore, a cancer-promoting mutation may appear only in a small number of cancer cases, if the underlying nucleotide change is too difficult to generate. We propose a method that integrates both the original mutation counts and their relative mutational difficulty. Using this method, we can accurately predict the functionality of hundreds of low-frequency missense mutations in p53, PTEN and INK4A. Many loss-of-function p53 mutations with dominant negative effects were identified, and the functional importance of several regions in p53 structure were highlighted by this analysis. Furthermore, mutational difficulty analysis also points to potential means of cancer prevention. Our study not only established relative mutational difficulties for different types of mutations in human cancer, but also showed that by incorporating such parameter, we can bring new angles to understanding cancer formation and prevention.
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Temporal order of mutations influences cancer initiation dynamics
H. Teimouri, A. B. Kolomeisky·bioRxiv·Jan 10, 2021
- Finding Driver Mutations in Cancer: Elucidating the Role of Background Mutational Processes
A.-L. Brown, M. Li, … A. R. Panchenko·bioRxiv·Apr 1, 2019
- Phenotypical mapping of TP53 unique missense mutations spectrum in human cancers
L. Malhotra, A. Singh, … A. S. Ethayathulla·bioRxiv·Feb 6, 2023
- Mutational likeliness and entropy help to identify driver mutations and their functional role in cancer
Giorgio Mattiuz, Salvatore Di Giorgio, … Silvestro G Conticello·bioRxiv·Jun 26, 2018
- The promoter mutation paucity as part of the dark matter of the cancer genome
Nicholas Allen Baclig Abad, Irina Glas, … Lars Feuerbach·bioRxiv·Jun 3, 2024
- A lottery simulation model for predicting cancer risk based on the strength and abundance of individual mutations
Alexander J Wolfe, Adam Giangreco·bioRxiv·Nov 15, 2016